| View |
|
DR-XY36142
|
5% Dextrose in Water
|
Unbranded
|
5g/ 100 mL (5% w/v)
|
Solution For I.V Infusion
|
Parenteral
|
Shanxi Nuocheng Pharm'l Co., Ltd.
|
China
|
Renewal
|
22 May 2024
|
08 July 2029
|
| View |
|
DR-XY36143
|
Sodium Chloride
|
Unbranded
|
900mg/100mL (0.9% w/v
|
Solution for IV Infusion
|
Rehydration Solution
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
Renewal
|
08 July 2024
|
03 July 2029
|
| View |
|
DR-XY36156
|
Thiamine Mononitrate (Vitamin B1) / Pyridoxine Hydrochloride (Vitamin B6) / Cyanocobalamin (Vitamin B12)
|
Neuronerv Forte
|
500 mg/250 mg/1000 mcg
|
Film-Coated Tablet
|
Vitamins
|
Lloyd Laboratores, Inc.
|
Philippines
|
Renewal
|
21 May 2024
|
06 July 2029
|
| View |
|
DR-XY36161
|
Carvedilol
|
Carvid
|
6.25 mg
|
Tablet
|
Beta Adrenergic Blocker/Antihypertensive
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
29 May 2024
|
03 July 2029
|
| View |
|
DR-XY36162
|
Carvedilol
|
Carvid
|
25 mg
|
Tablet
|
Beta Adrenergic Blocker/Antihypertensive
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
06 May 2024
|
03 July 2029
|
| View |
DR-XY36188_PI_01_NO RX SYMBOL.pdf
|
DR-XY36188
|
Bimatoprost + Timolol (as maleate)
|
Ganfort
|
300mcg/5mg per mL
|
Sterile Ophthalmic Solution
|
Antiglaucoma preparation and Miotic (Prostaglandin analogue and Beta blocking agent)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
10 March 2024
|
08 July 2029
|
| View |
|
DR-XY36189
|
Co-Amoxiclav
|
Altovox
|
457mg/ 5mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
06 May 2024
|
27 July 2029
|
| View |
|
DR-XY36211
|
Cefaclor (as monohydrate)
|
Cefazen
|
750 mg
|
Extended-Release Tablet
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
01 July 2024
|
08 July 2029
|
| View |
|
DR-XY36221
|
Desvenlafaxine (As Succinate)
|
Pristiq SR
|
50 mg
|
Extended-Release Tablet
|
-
|
Pfizer Ireland Pharmaceuticals
|
Ireland
|
Automatic Renewal
|
20 May 2021
|
27 June 2026
|
| View |
|
DR-XY36232
|
Norfloxacin
|
Uritracin
|
400 mg
|
Film - Coated Tablet
|
Urinary Antiseptic (Quinolone)
|
Ahmerst Laboratories, Inc.
|
Philippines
|
Renewal
|
23 August 2024
|
13 July 2029
|
| View |
|
DR-XY36235
|
Ciprofloxacin Hydrochloride
|
Xypen
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolones)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 April 2024
|
13 July 2029
|
| View |
|
DR-XY36245
|
Candesartan Cilexetil + Hydrochlorothiazide
|
Candez Plus
|
16 mg/12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic + Antihypertensive
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
23 January 2024
|
13 July 2029
|
| View |
|
DR-XY36247
|
Guaifenesin + Salbutamol (as sulfate)
|
Efamed Plus
|
100 mg/2 mg
|
Film Coated Tablet
|
Expectorant/ Selective Beta-2-adrenoreceptor Agonist
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
07 April 2024
|
13 July 2029
|
| View |
|
DR-XY36260
|
Glucose + Amino Acids + Electrolytes + Purified Soy Bean Oil
|
Kabiven Central
|
(See reverse Formulation)
|
Emulsion For Iv Infusion
|
Parenteral Nutrition
|
Fresenius Kabi AB
|
Sweden
|
Renewal
|
25 July 2024
|
14 July 2029
|
| View |
|
DR-XY36261
|
Glucose + Amino Acids + Electrolytes + Purified Soy Bean Oil
|
Kabiven Peripheral
|
(See reverse Formulation)
|
Emulsion For Iv Infusion
|
Parenteral Nutrition
|
Fresenius Kabi AB
|
Sweden
|
Renewal
|
02 July 2024
|
14 July 2029
|
| View |
|
DR-XY36275
|
Dexketoprofen (as Trometamol)
|
Ketesse
|
25mg
|
Film-Coated Tablet
|
Non-Steroidal Antiinflammatory Drug (NSAID)
(Propionic Acid Derivative)
|
A. Menarini Manufacturing Logistics and Services
S.R.L.
|
Italy
|
Initial (from Monitored Release Status)
|
17 May 2022
|
29 May 2027
|
| View |
|
DR-XY36278
|
Ciprofloxacin (As Hydrochloride)
|
Ceprotron
|
500 mg
|
Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
03 February 2021
|
16 July 2026
|
| View |
DR-XY36293_PI_01.pdf
|
DR-XY36293
|
Pioglitazone (as Hydrochloride) + Glimepiride
|
Asenza Plus
|
15mg/2mg
|
Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
-
|
12 April 2022
|
21 July 2025
|
| View |
|
DR-XY36314
|
Aciclovir
|
Zealor
|
400 mg
|
Tablet
|
Antiviral
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Renewal
|
21 April 2024
|
23 July 2029
|
| View |
|
DR-XY36319
|
Silver Sulfadiazine
|
Silvederma
|
1 g/100 g (1% w/w)
|
Cream
|
Antibacterial
|
Laboratorio Aldo Union, S.L.
|
Spain
|
Renewal
|
31 January 2024
|
23 July 2029
|